Research Article
[Retracted] DNM1: A Prognostic Biomarker Associated with Immune Infiltration in Colon Cancer—A Study Based on TCGA Database
Table 2
Logistic regression analysis of DNM1 expression associated with clinicopathological features.
| Characteristics | Total () | Odds ratio (OR) | |
| Age (>65 vs. ≤65) | 478 | 1.190 (0.826-1.716) | 0.352 | Gender (male vs. female) | 478 | 1.106 (0.772-1.585) | 0.583 | T stage (T3 & T4 vs. T1 & T2) | 477 | 1.311 (0.835-2.071) | 0.241 | N stage (N1 & N2 vs. N0) | 478 | 2.092 (1.445-3.042) | <0.001 | M stage (M1 vs. M0) | 415 | 1.885 (1.103-3.287) | 0.022 | Pathologic stage (Stage III & Stage IV vs. Stage I & Stage II) | 467 | 2.033 (1.402-2.960) | <0.001 | Perineural invasion (yes vs. no) | 181 | 2.744 (1.376-5.670) | 0.005 | Lymphatic invasion (yes vs. no) | 434 | 2.018 (1.364-3.001) | <0.001 |
|
|